Patient characteristics of the interim PET cohort (n = 99)
| Characteristics . | No. (%) . | Characteristics . | No. (%) . |
|---|---|---|---|
| Age, y | Treatment | ||
| ≤60 | 51 (52) | CHOP/ICE | 39 (39) |
| >60 | 48 (48) | CHOEP | 22 (22) |
| Sex | EPOCH | 1 (1) | |
| Male | 66 (67) | CHOP | 21 (21) |
| Female | 33 (33) | Other | 16 (16) |
| Histology | Transplant | ||
| PTCL-NOS | 38 (38) | Autologous | 61 (62) |
| AITL | 40 (40) | Allogeneic | 6 (6) |
| ALCL, ALK− | 21 (21) | None | 32 (32) |
| Ann Arbor stage | Interim PET by 5PS | ||
| I-II | 13 (13) | 1 and 2 | 78 (79) |
| III-IV | 86 (87) | 3 | 5 (5) |
| Performance status (ECOG) | 4 and 5 | 16 (16) | |
| 0-1 | 71 (72) | EOT PET by 5PS (n=90) | |
| 2-3 | 27 (27) | 1 and 2 | 68 (76) |
| NA | 1 | 3 | 2 (2) |
| Bone marrow involvement | 4 and 5 | 20 (22) | |
| No | 72 (73) | ||
| Yes | 27 (27) | ||
| LDH | |||
| Normal | 50 (51) | ||
| High | 45 (45) | ||
| NA | 4 (4) | ||
| IPI | |||
| 0-1 | 20 (20) | ||
| 2-3 | 61 (62) | ||
| 4-5 | 18 (18) | ||
| PIT | |||
| 0 | 17 (17) | ||
| 1 | 36 (36) | ||
| 2 | 25 (25) | ||
| 3 | 16 (16) | ||
| 4 | 5 (5) |
| Characteristics . | No. (%) . | Characteristics . | No. (%) . |
|---|---|---|---|
| Age, y | Treatment | ||
| ≤60 | 51 (52) | CHOP/ICE | 39 (39) |
| >60 | 48 (48) | CHOEP | 22 (22) |
| Sex | EPOCH | 1 (1) | |
| Male | 66 (67) | CHOP | 21 (21) |
| Female | 33 (33) | Other | 16 (16) |
| Histology | Transplant | ||
| PTCL-NOS | 38 (38) | Autologous | 61 (62) |
| AITL | 40 (40) | Allogeneic | 6 (6) |
| ALCL, ALK− | 21 (21) | None | 32 (32) |
| Ann Arbor stage | Interim PET by 5PS | ||
| I-II | 13 (13) | 1 and 2 | 78 (79) |
| III-IV | 86 (87) | 3 | 5 (5) |
| Performance status (ECOG) | 4 and 5 | 16 (16) | |
| 0-1 | 71 (72) | EOT PET by 5PS (n=90) | |
| 2-3 | 27 (27) | 1 and 2 | 68 (76) |
| NA | 1 | 3 | 2 (2) |
| Bone marrow involvement | 4 and 5 | 20 (22) | |
| No | 72 (73) | ||
| Yes | 27 (27) | ||
| LDH | |||
| Normal | 50 (51) | ||
| High | 45 (45) | ||
| NA | 4 (4) | ||
| IPI | |||
| 0-1 | 20 (20) | ||
| 2-3 | 61 (62) | ||
| 4-5 | 18 (18) | ||
| PIT | |||
| 0 | 17 (17) | ||
| 1 | 36 (36) | ||
| 2 | 25 (25) | ||
| 3 | 16 (16) | ||
| 4 | 5 (5) |
ECOG, Eastern Cooperative Oncology Group; LDH, lactate dehydrogenase; NA, not available; NS, not significant.